Dow Down1.40% Nasdaq Down1.59%

Onconova Therapeutics, Inc. (ONTX)

-NMS
4.26 Down 0.04(0.93%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 4,753   46,190   1,487  
Cost of Revenue -   -   -  
Gross Profit 4,753   46,190   1,487  
Operating Expenses
Research Development50,182  52,762  22,624  
Selling General and Administrative16,793  15,707  6,436  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (62,222) (22,279) (27,573)
Income from Continuing Operations
Total Other Income/Expenses Net105  975  1,298  
Earnings Before Interest And Taxes(62,117)(21,304)(26,275)
Interest Expense4  8,608  19  
Income Before Tax(62,121)(29,912)(26,294)
Income Tax Expense435   -   -  
Minority Interest13   -   -  
Net Income From Continuing Ops(62,543)(29,912)(26,294)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (62,543) (29,912) (26,294)
Preferred Stock And Other Adjustments(2,320)(3,953)(4,020)
Net Income Applicable To Common Shares (64,863) (33,865) (30,314)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.